| Authors: |
Casalone E; Department of Medical Sciences, University of Turin, Turin, Italy.; Italian Institute for Genomic Medicine, IIGM, Turin, Italy., Tachmazidou I; Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Zengini E; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.; 5th Psychiatric Department, Dromokaiteio Psychiatric Hospital of Athens, Athens, Greece., Hatzikotoulas K; Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Hackinger S; Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Suveges D; Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Steinberg J; Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Rayner NW; Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Wellcome Trust Centre for Human Genetics, Oxford, UK.; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK., Wilkinson JM; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., Panoutsopoulou K; Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Zeggini E; Human Genetics, Wellcome Trust Sanger Institute, Hinxton, UK. |
